230 related articles for article (PubMed ID: 12707418)
1. Current treatments for CIDP.
Ropper AH
Neurology; 2003 Apr; 60(8 Suppl 3):S16-22. PubMed ID: 12707418
[TBL] [Abstract][Full Text] [Related]
2. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kuntzer T
Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
[TBL] [Abstract][Full Text] [Related]
3. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
[TBL] [Abstract][Full Text] [Related]
5. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; van Schaik IN
Expert Opin Biol Ther; 2008 May; 8(5):643-55. PubMed ID: 18407767
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
9. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
Peltier AC; Donofrio PD
Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
Bright RJ; Wilkinson J; Coventry BJ
BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
[TBL] [Abstract][Full Text] [Related]
12. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?
Sladky JT
Muscle Nerve; 2008 Dec; 38(6):1638-43. PubMed ID: 19016535
[No Abstract] [Full Text] [Related]
13. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
Uzenot D; Azulay JP; Pouget J
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
[TBL] [Abstract][Full Text] [Related]
14. Initial treatment of childhood chronic inflammatory demyelinating polyradiculoneuropathy.
Teasley JE
Muscle Nerve; 2008 Dec; 38(6):1640-3. PubMed ID: 19125447
[No Abstract] [Full Text] [Related]
15. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Iijima M; Koike H; Sobue G
Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
[TBL] [Abstract][Full Text] [Related]
17. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
Oaklander AL; Gimigliano F
NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
[TBL] [Abstract][Full Text] [Related]
18. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Hughes R
J Clin Immunol; 2010 May; 30 Suppl 1():S70-3. PubMed ID: 20393791
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic inflammatory demyelinating polyneuropathy.
Kleyman I; Brannagan TH
Curr Neurol Neurosci Rep; 2015 Jul; 15(7):47. PubMed ID: 26008811
[TBL] [Abstract][Full Text] [Related]
20. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
